Martek trims Kentucky operations
This article was originally published in The Tan Sheet
Executive Summary
Martek Biosciences reduces its Winchester, Ky., workforce by about 45 people, nearly half its staffing at the facility, to offset infant formula price reductions, streamline operations and improve use of manufacturing capacity. Some manufacturing and distribution will move to Martek's Kingstree, S.C., site from Winchester, which lost about 100 workers during a 2006 restructuring (1"The Tan Sheet" Oct. 30, 2006). Martek expects to incur a non-cash asset impairment charge from the restructuring of $30 million to $40 million in the second half of its fiscal 2010. The Columbia, Md., nutritional oils firm said June 30 it plans to continue operations in Winchester, but potentially may sell or lease part of the facility
You may also be interested in...
Martek Expects Growth With Restructuring Plan, Including Layoffs
Martek Biosciences continues to push its growth with a new restructuring plan that should make it leaner and meaner, according to an Oct. 26 release
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.